Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04797858 · ClinicalTrials.gov registry record · NA
COVID-19 Self-Testing Through Rapid Network Distribution
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 792
- Enrollment target
NCT04797858: Completed NA study, sponsored by University of Pennsylvania.
NCT04797858 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 792 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04797858, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 792 participants
- Enrollment target
Study Summary
COVID-19, the coronavirus disease caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has led to a global pandemic and has exacerbated existing health inequities among vulnerable populations. Despite higher rates of COVID-19 in Black and Latinx individuals compared to White individuals, rates of testing in predominately non-White, low-income communities are significantly lower than in high-income areas. Self-testing, where individuals collect their own samples, is now feasible for the detection of SARS-CoV-2. One promising approach to increase test uptake is the secondary distribution of self-testing kits, where an individual distributes tests to contacts in their social network and encourages them to self-test. The central hypothesis of this clinical trial is that the secondary distribution of SARS-CoV-2 self-tests can significantly expand test uptake among underserved populations. To test this hypothesis, the investigators will conduct a 1:1 randomized controlled trial that will assess a self-testing intervention that promotes the secondary distribution of SARS-CoV-2 test kits compared with test referrals, with a focus on reaching underserved populations.
Interventions
- BEHAVIORAL COVID-19 self-test
- BEHAVIORAL COVID-19 test referral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 792 participants |
| Start Date | 2021-05-05 |
| Est. Completion | 2023-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04797858
The ClinicalTrials.gov registry entry for NCT04797858 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 792 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which COVID-19 self-test is the first listed.
NCT04797858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04797858 about?
NCT04797858 is a clinical study titled "COVID-19 Self-Testing Through Rapid Network Distribution". COVID-19, the coronavirus disease caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has led to a global pandemic and has exacerbated existing health inequities among vulnerable populations. Despite higher rates of COVID-19 in Black and Latinx individuals compared to White indiv...
What is the current status of trial NCT04797858?
This trial is currently completed. It is a NA study. The enrollment target is 792 participants. The study started on 2021-05-05. Estimated completion is 2023-11-29.
What interventions are being tested in trial NCT04797858?
The interventions under investigation include: COVID-19 self-test (BEHAVIORAL), COVID-19 test referral (BEHAVIORAL).
Who is sponsoring clinical trial NCT04797858?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.